[go: up one dir, main page]

WO2016178907A1 - Surveillance et conditionnement de tissus basés sur une myographie d'impédance électrique - Google Patents

Surveillance et conditionnement de tissus basés sur une myographie d'impédance électrique Download PDF

Info

Publication number
WO2016178907A1
WO2016178907A1 PCT/US2016/029812 US2016029812W WO2016178907A1 WO 2016178907 A1 WO2016178907 A1 WO 2016178907A1 US 2016029812 W US2016029812 W US 2016029812W WO 2016178907 A1 WO2016178907 A1 WO 2016178907A1
Authority
WO
WIPO (PCT)
Prior art keywords
patient
electrodes
garment
actuator
pair
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2016/029812
Other languages
English (en)
Inventor
Seward RUTKOVE
Jose Bohorquez
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SKULPT Inc
Original Assignee
SKULPT Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SKULPT Inc filed Critical SKULPT Inc
Publication of WO2016178907A1 publication Critical patent/WO2016178907A1/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0452—Specially adapted for transcutaneous muscle stimulation [TMS]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves
    • A61B5/053—Measuring electrical impedance or conductance of a portion of the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4836—Diagnosis combined with treatment in closed-loop systems or methods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
    • A61F7/007—Heating or cooling appliances for medical or therapeutic treatment of the human body characterised by electric heating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H9/00—Pneumatic or hydraulic massage
    • A61H9/005—Pneumatic massage
    • A61H9/0078—Pneumatic massage with intermittent or alternately inflated bladders or cuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0472—Structure-related aspects
    • A61N1/0484—Garment electrodes worn by the patient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/36014—External stimulators, e.g. with patch electrodes
    • A61N1/3603—Control systems
    • A61N1/36031—Control systems using physiological parameters for adjustment
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/30—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to physical therapies or activities, e.g. physiotherapy, acupressure or exercising
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A61B5/316—Modalities, i.e. specific diagnostic methods
    • A61B5/389—Electromyography [EMG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/45—For evaluating or diagnosing the musculoskeletal system or teeth
    • A61B5/4519—Muscles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6801—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
    • A61B5/6802—Sensor mounted on worn items
    • A61B5/6804—Garments; Clothes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
    • A61F2007/0091—Heating or cooling appliances for medical or therapeutic treatment of the human body inflatable
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
    • A61F7/02—Compresses or poultices for effecting heating or cooling
    • A61F2007/0225—Compresses or poultices for effecting heating or cooling connected to the body or a part thereof
    • A61F2007/0233—Compresses or poultices for effecting heating or cooling connected to the body or a part thereof connected to or incorporated in clothing or garments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H2201/00—Characteristics of apparatus not provided for in the preceding codes
    • A61H2201/02—Characteristics of apparatus not provided for in the preceding codes heated or cooled
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H2201/00—Characteristics of apparatus not provided for in the preceding codes
    • A61H2201/02—Characteristics of apparatus not provided for in the preceding codes heated or cooled
    • A61H2201/0207—Characteristics of apparatus not provided for in the preceding codes heated or cooled heated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H2201/00—Characteristics of apparatus not provided for in the preceding codes
    • A61H2201/10—Characteristics of apparatus not provided for in the preceding codes with further special therapeutic means, e.g. electrotherapy, magneto therapy or radiation therapy, chromo therapy, infrared or ultraviolet therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H2201/00—Characteristics of apparatus not provided for in the preceding codes
    • A61H2201/12—Driving means
    • A61H2201/1207—Driving means with electric or magnetic drive
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H2201/00—Characteristics of apparatus not provided for in the preceding codes
    • A61H2201/16—Physical interface with patient
    • A61H2201/1602—Physical interface with patient kind of interface, e.g. head rest, knee support or lumbar support
    • A61H2201/1619—Thorax
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H2201/00—Characteristics of apparatus not provided for in the preceding codes
    • A61H2201/16—Physical interface with patient
    • A61H2201/1602—Physical interface with patient kind of interface, e.g. head rest, knee support or lumbar support
    • A61H2201/1635—Hand or arm, e.g. handle
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H2201/00—Characteristics of apparatus not provided for in the preceding codes
    • A61H2201/16—Physical interface with patient
    • A61H2201/1602—Physical interface with patient kind of interface, e.g. head rest, knee support or lumbar support
    • A61H2201/164—Feet or leg, e.g. pedal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H2201/00—Characteristics of apparatus not provided for in the preceding codes
    • A61H2201/16—Physical interface with patient
    • A61H2201/1602—Physical interface with patient kind of interface, e.g. head rest, knee support or lumbar support
    • A61H2201/1645—Physical interface with patient kind of interface, e.g. head rest, knee support or lumbar support contoured to fit the user
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H2201/00—Characteristics of apparatus not provided for in the preceding codes
    • A61H2201/16—Physical interface with patient
    • A61H2201/1602—Physical interface with patient kind of interface, e.g. head rest, knee support or lumbar support
    • A61H2201/165—Wearable interfaces
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H2201/00—Characteristics of apparatus not provided for in the preceding codes
    • A61H2201/50—Control means thereof
    • A61H2201/5058—Sensors or detectors
    • A61H2201/5064—Position sensors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H2201/00—Characteristics of apparatus not provided for in the preceding codes
    • A61H2201/50—Control means thereof
    • A61H2201/5058—Sensors or detectors
    • A61H2201/5071—Pressure sensors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H2230/00—Measuring physical parameters of the user
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H2230/00—Measuring physical parameters of the user
    • A61H2230/08—Other bio-electrical signals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H2230/00—Measuring physical parameters of the user
    • A61H2230/20—Blood composition characteristics
    • A61H2230/207—Blood composition characteristics partial O2-value
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H2230/00—Measuring physical parameters of the user
    • A61H2230/25—Blood flowrate, e.g. by Doppler effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H2230/00—Measuring physical parameters of the user
    • A61H2230/30—Blood pressure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H2230/00—Measuring physical parameters of the user
    • A61H2230/40—Respiratory characteristics
    • A61H2230/42—Rate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H2230/00—Measuring physical parameters of the user
    • A61H2230/50—Temperature
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H2230/00—Measuring physical parameters of the user
    • A61H2230/50—Temperature
    • A61H2230/505—Temperature used as a control parameter for the apparatus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H2230/00—Measuring physical parameters of the user
    • A61H2230/60—Muscle strain, i.e. measured on the user, e.g. Electromyography [EMG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H2230/00—Measuring physical parameters of the user
    • A61H2230/60—Muscle strain, i.e. measured on the user, e.g. Electromyography [EMG]
    • A61H2230/605—Muscle strain, i.e. measured on the user, e.g. Electromyography [EMG] used as a control parameter for the apparatus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H23/00—Percussion or vibration massage, e.g. using supersonic vibration; Suction-vibration massage; Massage with moving diaphragms
    • A61H23/02—Percussion or vibration massage, e.g. using supersonic vibration; Suction-vibration massage; Massage with moving diaphragms with electric or magnetic drive
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H9/00—Pneumatic or hydraulic massage
    • A61H9/005—Pneumatic massage
    • A61H9/0078—Pneumatic massage with intermittent or alternately inflated bladders or cuffs
    • A61H9/0092—Cuffs therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0456—Specially adapted for transcutaneous electrical nerve stimulation [TENS]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/321—Electromedical belts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/36003—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation of motor muscles, e.g. for walking assistance

Definitions

  • Embodiments of the present disclosure relate generally to systems and methods for monitoring and/or conditioning of body tissue using electrical impedance myography (EIM). Some embodiments of the present disclosure relate to sensors and/or devices to detect electrical impedance of tissue and devices and/or methods to apply treatment based on the detected impedance. Some embodiments of the disclosure relate to methods for evaluating the health of tissue (e.g., human tissue) and measurement schemes to improve the sensitivity to change in health over time.
  • tissue e.g., human tissue
  • EIM Electrical impedance myography
  • EMG needle electromyography
  • EIM does not focus on measuring the inherent electrical activity of the tissues.
  • EMG needle electromyography
  • measurements are made over a small area of interest, with energy being applied to the body and the resultant surface patterns being analyzed.
  • EIM electrical current is used and the output is a set of quantitative parameters describing the state of the tissue.
  • Examples of the present disclosure relate to, among other things, devices, systems, and methods for electrical impedance myography based monitoring and conditioning of tissue.
  • Each of the examples disclosed herein may include one or more of the features described in connection with any of the other disclosed examples.
  • a wearable treatment device for a patient may include at least one electrode coupled to a garment configured to be worn by the patient, the at least one electrode being configured to be placed in contact with the patient's tissue and measure electrical impedance of the patient; and at least one actuator operatively coupled to the garment, the at least one actuator being configured to deliver a treatment to the patient in response to the measured electrical impedance.
  • the treatment device may additionally or alternatively include one or more of the following features: the measured electrical impedance may indicate a change in a muscle characteristic; the at least one actuator may include a plurality of inflatable cuffs configured to apply pressure to a portion of the patient; the at least one actuator may include a heater; the at least one actuator may be configured to deliver electrical stimulation to the patient; the at least one actuator may be configured to vibrate; the at least one electrode may include a first pair of spaced apart current electrodes and a second pair of spaced apart voltage electrodes, and the device may be configured to direct a current into the patient's tissue through the first pair of current electrodes and measure a voltage across the second pair of voltage electrodes; and the at least one electrode may include multiple pairs of current electrodes and multiple pairs of voltage electrodes.
  • a method for treating a patient may include positioning a garment around a portion of the patient, wherein the garment is coupled to at least one electrode positioned in contact with the patient's tissue; measuring electrical impedance of the patient using the at least one electrode; and in response to the measured electrical impedance, using at least one actuator operatively coupled to the garment to deliver a treatment to the patient.
  • the method may additionally or alternatively include one or more of the following features or steps: the measured electrical impedance may indicate a change in a muscle characteristic; the at least one actuator may include a plurality of inflatable cuffs, and the method may further include inflating the plurality of cuffs in sequence; the method may further include using the actuator to apply heat to the patient; the method may further include using the actuator to deliver electrical stimulation to the patient; and the at least one electrode may include a first pair of spaced apart current electrodes and a second pair of spaced apart voltage electrodes, and the method may further include directing a current into the patient's tissue through the first pair of current electrodes and measuring a voltage across the second pair of voltage electrodes.
  • a system for treating a patient may include a garment; a plurality of electrodes coupled to the garment, wherein the plurality of electrodes are configured to obtain electrical impedance data relating to one or more muscles of the patient; a computational device configured to detect an anomaly in the electrical impedance data; and a plurality of actuators coupled to the garment and configured to deliver a treatment to the patient in response to the anomaly in the electrical impedance data.
  • the system may additionally or alternatively include one or more of the following features: the anomaly may be a measured impedance signal that exceeds a threshold value; the garment may include a shirt, and the shirt may include a plurality of electrodes configured to be positioned adjacent an abdomen, a plurality of electrodes configured to be positioned adjacent a bicep, a plurality of electrodes configured to be positioned adjacent a tricep, and a plurality of electrodes configured to be positioned adjacent a back; the plurality of electrodes may include a first pair of spaced apart current electrodes and a second pair of spaced apart voltage electrodes, and the system may be configured to direct a current into the patient's tissue through the first pair of current electrodes and measure a voltage across the second pair of voltage electrodes; the at least one actuator may be configured to at least one of deliver heat, electrical stimulation, or vibrations to the patient; and the at least one actuator may be inflatable.
  • FIG. 1 A illustrates a system for treating a patient, according to an exemplary embodiment.
  • FIG. IB illustrates a sensor having a pattem of electrodes, according to an exemplary embodiment.
  • FIG. 2A illustrates the progression of a disease over time, according to an exemplary embodiment.
  • FIG. 2B illustrates the progression of a disease over time using more frequent EIM measurements than the progression shown in FIG. 2A, according to an exemplary embodiment.
  • FIG. 3 illustrates an exemplary method of characterizing disease progression using frequent EIM measurements, according to an exemplary embodiment.
  • EIM sensors may be used to detect physiological parameters of a subject.
  • these EIM sensors may be wearable sensors. Based on the detected signals, muscle condition and/or health of the subject may be determined.
  • these sensors may be attached to the subject by any means (e.g., adhesive, etc.).
  • Sensors may include electrodes, devices, etc. that are adapted to produce a signal in response to a bioelectric signal of the subject.
  • the sensors may be embedded in a garment that may be worn by the subject. The garment may be worn over any part of the body (e.g., legs, arms, trunk, neck, head, etc.).
  • the same garment, or more than one garment, may be used to target different muscle groups, such as the biceps, triceps, abdomen, back, chest, and calves.
  • the term "garment” is intended to refer to any type of clothing or accessory worn by, draped on, or placed on the subject.
  • the garment may include: a patch that is placed over muscle and held in place by bands (e.g., Velcro straps, etc.) or adhesive materials; a cuff that is wrapped around the limb or portion of a limb (similar to a blood pressure cuff) and secured with Velcro strips, bands, or adhesives; snug-fitting or close fitting clothing, including shirts, pants, gloves, socks, hats, etc.; belts; straps; a neck wrap; trunk wrap (e.g. corset); etc.
  • bands e.g., Velcro straps, etc.
  • a cuff that is wrapped around the limb or portion of a limb (similar to a blood pressure cuff) and secured with Velcro strips, bands, or adhesives
  • snug-fitting or close fitting clothing including shirts, pants, gloves, socks, hats, etc.
  • belts e.g. corset
  • the sensors are described as being embedded in the garment, in some embodiments, some or all of the sensors may be attached (
  • the sensors may be incorporated in a portable device that the user may periodically press against the user's skin to take measurements.
  • the sensors are described as being incorporated in a garment in the description below, it should be recognized that the description is also applicable when the sensors are incorporated in a portable device.
  • Electronic components or devices associated with (e.g., operatively coupled to) the garment or portable device may receive the EIM signals measured by the sensors and determine muscle condition and health of the subject based on the signals.
  • the signals measured by the sensors may include electrical impedance measurements.
  • the measured electrical impedance may indicate a muscle characteristic (e.g., structure, composition) of the subject, and changes in the electrical impedance may indicate changes in the muscle characteristic.
  • the sensors embedded in the garment (device, etc.) may be operationally coupled to the associated electronic components by any means.
  • the sensors may have a direct hardwire connection (e.g., wire) to these components.
  • the sensors may be wirelessly connected to the electronic components (e.g., Bluetooth, etc.).
  • the sensors and/or their associated electronic components also may include circuitry and/or components configured to enhance the accuracy (e.g., filters, etc.) and extend the range of capability (amplifiers, etc.) of the measured impedance-related data.
  • the sensors and the associated electronic components may use impedance techniques to determine the status and/or health of the subject.
  • the phrase health of the subject is used to broadly refer to any parameter that is indicative of the health or well-being of a particular muscle/region of the subject or a parameter indicative of overall health of the subject.
  • health of the subject may include parameters such as muscle percentage, fat percentage, muscle quality (MQ), etc.
  • the sensors and/or the associated electronic components may be configured to determine the health of the subject by any known method/technique.
  • methods/techniques may include, among others, 4-electrode impedance measurements, whole body bioimpedance analysis, impedance phlebography, impedance cardiography, impedance pulmonography, hydration status, surface electromyography, skin temperature measurement, electrocardiography, pulse oximetry, muscle tonometry measurements (to assess strength of contraction), diagnostic ultrasound, etc.
  • the sensors may include accelerometers for measurement of movement and sensors to measure blood pressure or any other biological parameter, etc.
  • the sensors may also detect additional electrical impedance data, such as, for example, for assessment of hydration, cardiac output, localized blood flow, breathing rate and vital capacity; electromyographic signal data including individual motor unit potential data, recruitment and interference partem data; temperature at one or multiple locations along the garment, including measurement of temperature differentials between sensors; electrocardiogram data, including, pulse rate, heart-rate variability; blood pressure at specific areas where sensors are located, including blood pressure differentials; blood oxygenation levels; movement of body or specific limbs/muscles, including specific number of muscle or length of muscle contractions; strength and duration of muscle-specific contractions; ultrasound data on underlying muscle and subcutaneous fat.
  • additional electrical impedance data such as, for example, for assessment of hydration, cardiac output, localized blood flow, breathing rate and vital capacity; electromyographic signal data including individual motor unit potential data, recruitment and interference partem data; temperature at one or multiple locations along the garment, including measurement of temperature differentials between sensors; electrocardiogram data, including, pulse rate, heart-rate variability; blood pressure at specific areas where sensors
  • Hydration sensors if any, included in the garment may have different forms. These sensors may include the use of electrodes embedded in the garment (pants, shirt, etc.) to measure the trans-lower-extremity or trans-upper-extremity impedances versus thoracic or localized impedances to provide data on the overall hydration status of the body. In some embodiments, this sensor also may be a cuff around a limb that may be used to provide electrical impedance data of both the large veins and arteries (the measures of hydration status) versus more superficial muscle regions.
  • the garment also may include sensors configured for location detection (GPS sensors), altimeter/barometric pressure detection, external temperature, etc.
  • the data collected by the sensors may include, but is not restricted to, the following: electrical impedance data obtained from muscle, fat, and skin as part of electrical impedance myography methods using electrode arrangements and methods described in co-assigned U.S. Patent No. 8,892,198, issued November 18, 2014 (the ⁇ 98 patent), co-assigned U.S. Patent No. 9,113,808, issued August 25, 2015 (the '808 patent), and the '821 application, each of which is incorporated by reference in its entirety herein.
  • the disclosed technique in addition to sensing, also may apply a treatment or other conditioning to the subject.
  • the treatment may be administered in response to a health condition detected by the sensors coupled to the subject.
  • the treatment may include a treatment to improve the muscle performance or condition.
  • treatment may be administered to improve muscle condition even when a deteriorating muscle condition is not detected.
  • any type of treatment may be administered to the subject.
  • the treatment may include one or more of the following: application of heat or cooling to specific regions of muscle (e.g., relative to the patient's body temperature);
  • electrical stimulation of muscle or nerves including massage (e.g., through peristalsis-like motion of a wrapped fabric); vibration at varying frequencies; application of induced magnetic fields; application of therapeutic ultrasound; iontopheresis of therapeutic small molecules; activating flow a drug or a medicine into the subject (e.g., from a vial implanted or fluidly coupled to the subject); activating a interventional device (e.g., implanted in the patient); etc.
  • the treatments may be administered by one or more actuators associated with the sensors.
  • the term "actuator" is intended to include any device or mechanism that may cause an effect on the subject.
  • the treatment may be administered using the same sensors used to sense EIM signals or other information related to the patient (e.g., if the treatment is electrical stimulation). Accordingly, the sensors may act as actuators.
  • some or all of these actuators may be embedded in the garment or within the subject.
  • the garment may assist in treatment of a health condition detected by the sensors, or may assist in improving the muscle characteristics of the patient.
  • Some or all of these actuators may be interfaced directly with the impedance or other measuring systems as well as with separate, stand-alone devices such as a smart phone, tablet or desktop computer. They also may be directly connected to Wi-Fi or wireless networks as deemed appropriate.
  • Each of the measurements may be used in conjunction with each other such that detailed data on the body and specific muscles can be obtained.
  • one technology could be used to specifically improve the accuracy and interpretation of the data obtained with a second modality.
  • multiple modalities may be used to infer a more accurate status of the body's or muscle's condition.
  • These technologies may include (but are not limited to): using electrical impedance data to improve/filter an EMG signal; adjusting electrical impedance data based on a recorded temperature; evaluating pulse oximetry data in conjunction with movement data to evaluate level of fatigue and onset of muscle injury; using tonometry data and EMG data to assess the level of contraction to assess changes in impedance data; combining movement, oximetry, EMG, tonometry, and impedance data to provide measure of muscle status and onset of fatigue.
  • measurements may provide information to: help/inform onset of muscle injury and identify appropriate treatments; avoid overtraining; measure effort level and at what point a maximum is reached; reduce the development of muscle atrophy and weakness in hospitalized patients; measure long term changes in muscle quality, muscle endurance (body composition, muscle quality, muscle endurance, muscle recovery capability, etc.); measure short term changes (fatigue, exertion levels, form, heart rate and HRV, temperature, etc.); use in spaceflight or underwater to monitor muscle atrophy; measure the impact of disease on normal muscle function; and measure whole body and localized region hydration status so as to better understand the impact on muscle condition.
  • the disclosed system and method may be used by a user performing exercise.
  • the user may wear one or more garments that include the sensors (e.g., cuffs with sensors worn over different muscles) and one or more garments that include actuators (e.g., wraps that include treatment modalities (heaters, air cuff to apply).
  • the sensors e.g., cuffs with sensors worn over different muscles
  • actuators e.g., wraps that include treatment modalities (heaters, air cuff to apply
  • the sensors may measure muscle characteristics (e.g., bicep MQ, tricep MQ, etc.) through EIM measurements.
  • muscle characteristics e.g., bicep MQ, tricep MQ, etc.
  • one or more actuators e.g., positioned on the bicep
  • the disclosed measurement systems may be used in conjunction with environmental measures to assess the physiologic adaption to environmental alterations, including changes in altitude, temperature or barometric parametric.
  • environmental measures including changes in altitude, temperature or barometric parametric.
  • these measurements can be used in combination to ensure appropriate and accurate application of the actuators.
  • actuators may include but would not be limited to the following: treatment and prevention of impending fatigue with massage or compression; treatment of muscle injury with cooling, heating or magnetic fields; application of muscle heating to improve performance metrics; use of vibration to treat muscle discomfort (as indicated by increased heart rate at rest, for example); electrical stimulation to treat muscle discomfort or increase blood oxygentation; compression to increase blood flow to active limbs or to account for elevated altitude; iontopheresis of drugs and other therapies to mitigate pain and improve performance; improve function in weak muscles/limbs; and prevention and treatment of low back or neck discomfort, indicated by electromyographic, tonographic, and impedance-based, via use of compression, vibration, ultrasonography, or iontophoretic therapy.
  • any of the treatments referenced herein may be used to improve muscle condition for fitness, aesthetic, or other reasons, even absent underlying fatigue, injury, discomfort, pain, or decrease in function.
  • a sensor array in a shirt or similar garment may obtain data on the truncal muscles, including abdominal and back muscles to provide real time assessment of position/condition of these muscles and apply a treatment as a remedy to a detected muscle condition (e.g., to help prevent and alleviate back pain).
  • FIG. 1 A illustrates an exemplary embodiment of a system used to detect and apply treatment to the abdominal muscles of a subject.
  • the system of FIG. 1A includes a garment 30 worn by a subject 100.
  • Garment 30 includes a wrap positioned around the subject's trunk.
  • Garment 30 may include a plurality of actuators in the form of inflatable cuffs 20 A, 20B, 20C (similar to blood pressure monitoring cuffs) that may be selectively or collectively inflated by a compressed fluid (air, liquid, etc.).
  • the fluid for inflation may be provided in a canister (not shown) included in the garment 30.
  • the canister may be provided on the person of subject 100. It is also contemplated that, in some embodiments, a remotely positioned canister may be fluidly coupled to the garment 30 for the purposes of inflation and deflation.
  • Garment 30 also includes a plurality of sensors 10 embedded therein (or attached thereto).
  • the sensors 10 may be configured to detect EIM signals associated with the muscles in the subject's back.
  • the measured electrical impedance may be indicative of the health condition of the back muscles.
  • the sensors 10 may direct (e.g., transmit wirelessly or transfer through a wired connection) the measured EIM signals to a computational device 50 positioned remote from the subject 100.
  • the collected data may be continuously or periodically transmitted to the device 50. The frequency of the periodic transmission may be selected by a user.
  • the garment 30 may be associated with a memory to store the collected EIM data. This memory may be incorporated into the garment 30 or otherwise coupled to the garment 30. In such embodiments, the collected EIM data may be stored in the memory and downloaded to device 50 when desired (e.g., during a visit to a doctor).
  • Sensors 10 may include a pattern of electrodes 18a- 181 (referred to collectively as electrodes 18), as shown in FIG. IB.
  • FIG. IB illustrates an exemplary partem of electrodes 18 that may be included on an interior of garment 30.
  • Electrodes 18 may include any electrically conductive material (e.g., copper, aluminum, silver, gold, etc.).
  • the electrodes 18 may be coated with (or treated with) another material to impart desirable properties to the electrodes 18 (e.g., oxidation, wear, and/or corrosion resistance, decreased interfacial contact resistance, etc.).
  • the electrodes 18 may protrude from the surface of the garment 30 on which they are positioned.
  • the electrodes 18 may be flush with, or recessed relative to, the surface.
  • the electrodes 18 may include a first pair of spaced apart current electrodes and a second pair of spaced apart voltage electrodes, wherein the device is configured to direct a current into the patient's tissue through the first pair of current electrodes and measure a voltage across the second pair of voltage electrodes.
  • twelve electrodes 18a- 181 may be arranged in a partem to allow different configurations to be used in a measurement. In general, the electrodes 18 may be arranged in any desired pattern.
  • the electrodes 18 may be arranged in a partem about a central axis 22 of the device 10 that extends perpendicular to the surface on which the electrodes 18 are positioned.
  • electrodes 18 may include a plurality of electrodes 18g, 18i, 18k, and 18h spaced apart and arranged parallel to a first axis 24 and a plurality of electrodes 18a, 18b, 18c, 18j, 181, 18d, 18e, and 18f spaced apart and arranged parallel to a second axis 26 perpendicular to the first axis 24.
  • Device 50 may be configured to analyze (e.g., using software) the received signals to determine the health of the muscles.
  • the analysis may detect an anomaly associated with the muscles (e.g., a sprain, etc.).
  • the analysis may include computations using the collected EIM data.
  • the analysis may include a review of the collected EIM data. If an anomaly is detected (e.g., a computed parameter or the measured signal exceeds a threshold value, a signal pattern resembles a pattern associated with an anomaly, etc.), device 50 may activate the cuffs 20 A, 20B, 20C embedded in the garment 30 to administer a treatment to the back muscles.
  • fluid from the canister may inflate the cuffs 20A, 20B, 20C to compress (or massage) the muscles.
  • the device 50 may selectively activate the cuffs 20A, 20B, 20C in response to detection of an anomaly.
  • cuffs 20A, 20B, and 20C may be inflated in sequence to administer a peristalsis-like massage treatment to the muscles.
  • heaters and/or other actuators also may be incorporated into the garment 30 to apply additional (or alternate) treatment to the muscles.
  • device 50 may activate the cuffs 20A, 20B, 20C, and for other anomalies the device 50 may, additionally or alternatively, activate the heaters to apply heat as treatment.
  • the treatment may be stopped by any method.
  • the subject may press a button (e.g., associated with garment 30) to stop the treatment.
  • the treatment may be stopped after a pre-programmed time. It is also contemplated that, in some embodiments, the treatment may be stopped when the sensors 10 indicate that the health of the muscles have improved.
  • the computational device 50 is illustrated as a computer positioned close to subject 100, this is not a requirement.
  • device 50 may be any electronic component (server, iPad, tablet, etc.) with software adapted to analyze the signals from the sensors 10.
  • Device 50 may be placed at any location.
  • device 50 may be portable and may be carried by (or be attached to) the subj ect.
  • the device 50 may be positioned at a remote site (e.g., a remote health monitoring facility or a doctor's office).
  • an auxiliary device 40 carried by (or attached to) the patient may receive the signals from the sensors 10 and transmit (e.g., using a cellular network) the signals to the remotely positioned device 50.
  • the actuators may be separate from, but operationally coupled with (e.g., synced to), the sensors in the garment.
  • the actuators may be incorporated into automated chairs, beds, or recliners, such that the position of lumbar support of the furniture may be modified to actuate and reduce the identified discomfort of the subject.
  • the device 50 may activate a reclining bed that the patient is lying on to a more comfortable position.
  • an actuator may be used to apply cooling to a limb by a wrap after identifying alterations in the muscle impedance data during an activity (e.g., exercise). Impedance changes during an activity may indicate excessive muscle injury after heavy exertion and a wrap around a limb may provide cooling therapy.
  • a compression actuator e.g., cuffs 20A, 20B, 20C also may increase pressure if there is evidence of fatigue in the muscle.
  • some embodiments of the current disclosure may include longer-term measurement and therapy.
  • the ability to track nerve and muscle disease progression and its response to drug therapy remains challenging for a variety of reasons. These reasons include the general slowness of disease progression (often only detectable over the course of several months or even a year or longer), the absence of effective outcome measures or biomarkers of disease progression (since functional measures are often challenging to employ and imaging modalities are limited), and considerable variability in disease progression across individuals and their response to therapy. A similar situation exists, although changes are somewhat faster, for other conditions that involve muscle, including disuse atrophy or muscle injury from overuse.
  • evaluating changes in body composition and fat content may be similarly slow. For example, it may be difficult to observe the effects of decreasing fat % in the body during a low calorie diet or during an exercise program. These changes could be used to help modify risk factors for diseases such as, for example, Type 2 diabetes (i.e., increased muscle mass and reduced fat content reduce the likelihood of developing Type 2 diabetes). Frequent measurements of EIM signals may assist in identifying the impact of drug treatments that effect the deposition of fat. For example, corticosteroid use is known to increase fat % in specific body regions, including the face, upper back and abdomen, with relatively less impact on the extremities.
  • EIM measurements also may be used to evaluate neuromuscular disease progression, including in amyotrophic lateral sclerosis, muscular dystrophy, spinal muscular atrophy, disuse atrophy, and even polyneuropathy.
  • Standard clinical trial research approaches for employing EIM envision it being applied at several-month intervals along with standard measures of disease progression (e.g., questionnaires, strength testing, functional tests and imaging (e.g., MRI)). Whereas ordinary modalities of testing can only be reasonably applied on an intermittent basis by trained individuals or are insensitive to change over very short intervals, EIM measures and associated improvements as noted above in this application can be performed frequently at home by patients or their family
  • the term "frequent" in this disclosure is used to indicate an inter-measurement time that is significantly less than (or a measurement frequency that is significantly more than) the several-month intervals between typical EIM measurements.
  • the frequency of a frequent measurement of the current disclosure may depend upon the disease being monitored, in all embodiments, the frequency of measurement is greater than or equal to one measurement per month.
  • the term frequent measurement refers to multiple measurements per month (e.g., one measurement every two weeks, one measurement every week, etc.) In some embodiments, it refers to multiple measurements per week (e.g., one measurement every few days, one measurement every day, etc.).
  • the term frequent measurement refers to multiple measurements per day (e.g., one measurement every few hours, one measurement per hour, multiple measurements per hour, etc.).
  • a user may carry out frequent measurements at home, without the assistance of a medical professional. All or a portion of the frequent measurements may be conducted using the same sensor (e.g., a sensor 10 shown in FIGs. 1 and 1A). In some cases, the sensor 10 may remain in contact with the user's skin between the frequent measurements.
  • the senor 10 may remain in contact with the patient's skin for a plurality of the frequent measurements (e.g., the measurements during the course of a day), although the user may remove the sensor 10 at certain times (e.g., to shower).
  • the sensor 10 may be a part of garment 30 or may be any other sensor 10 secured to the patient's skin and/or used during the frequent measurements.
  • the EIM measurements may be taken by a user periodically pressing electrodes/sensors incorporated in a portable device against the user's skin.
  • FIGS. 2 A and 2B show the basic concepts underlying the ability to obtain frequent measurements over longer periods of time and the improved ability to detect change.
  • FIG. 2A illustrates a typical case where data of a patient with a progressive disease is measured once every 100 days.
  • Curve 55 is a plot of disease progression, assuming a linear decline over time (a standard assumption in most neuromuscular disease clinical trials).
  • the dashed lines 60 in FIG. 2A represent the 95% confidence intervals for the slope of decline over time.
  • FIG. 2B illustrates the results of an exemplary frequent measurement technique in which data of the patient is measured frequently. As can be seen in FIG.
  • sample size determination i.e., determination of the number of subjects needed for a clinical trial
  • standard methods for two-level mixed-effects model analysis assuming a clinical trial in which we were seeking to identify a treatment effect after 6 months.
  • we assumed a linear progression of the disease with alpha 0.05, a two-tailed Wald test, with equal randomization between drug and placebo, with between- subject variability being four times greater than within-subject variability and an intra-class correlation coefficient for the measurements of 0.80, seeking a treatment effect of 0.5 SD in a given parameter.
  • a child is assessed at baseline, and then every 2 months for a total of 4 assessments.
  • Embodiments of the disclosed frequent measurement approach may be used in ALS clinical trials, muscular dystrophy clinical trials, or any other disorder characterized by a progressive change in the condition of muscle, whether a deterioration or an improvement in the condition of muscle is being identified (e.g., the graphs in FIG. 2B could show an improving trend over time and it would therefore be easier to identify improvement rather than just a slowing of deterioration).
  • a deterioration or an improvement in the condition of muscle is being identified
  • One example of this may be in the treatment of sarcopenia where over the time of a clinical trial no appreciable change in the character of the muscle will be observed in a placebo group. If a patient were placed on a medication to improve muscle condition or an exercise therapy program or both in combination, the frequent measurements may mean that a treatment effect could be identified much more readily, with fewer people, over shorter periods of time, and at lower cost.
  • FIG. 3 illustrates an exemplary method 200 of characterizing disease progression using frequent EIM measurements.
  • the EIM measurements may be made at frequent intervals (1/day, 1/2 days, 1/week, etc.) using an EIM measurement device (step 210). Any EIM measurement device may be used for these measurements.
  • a measurement device disclosed in the ⁇ 98 patent and the '808 patent (which are incorporated by reference herein) may be used for frequent EIM measurements.
  • garment 30 of FIG. 1A may be used as the EIM measurement device.
  • the EIM data may be measured by the patient or a caregiver using the EIM measurement device.
  • the collected EIM data may be uploaded or transferred to a cloud server, a remote database, or a remote computational device (such as device 50 of FIG. 1 A) for analysis (step 220).
  • the collected data may be uploaded to the remote database at any frequency (e.g., continuously, periodically, etc.). In some embodiments, the collected data may be uploaded based on a request from the remote database. In some embodiments, instead of uploading, the data may be stored in the EIM measurement device. The stored data then may be transferred to a remote database as desired (e.g., using a disk, memory device, etc.). It also is contemplated that, in some embodiments, the collected data may not be transferred to the remote database. Instead, analysis on the stored data may be performed on the EIM measurement device.
  • the central database may perform analysis on the received data to determine a health parameter of the patient (step 230).
  • the health parameter may be an indicator of the disease or other change being monitored by the EIM measurement device.
  • the health parameter may be a muscle characteristic indicative of a change (e.g., deterioration or improvement) of one or more muscles in response to a lack of or an increase in exercise.
  • the ⁇ 98 patent, the '808 patent, and the '821 application describe some of the analysis that may be performed by the database. In general, the type of analysis performed by the database may depend upon the disease being monitored. Since analysis techniques and algorithms to detect diseases monitored using the EIM measurement device (discussed previously) are known in the art, these techniques are not discussed herein.
  • the collected EIM data may itself indicate the health of the patient and the progression of the disease.
  • the analysis may only include a review of the collected data.
  • the determined health parameter may be plotted over time to indicate the progression of the monitored disease or health parameter over time (step 240).
  • the data may be plotted on a display device (screen) associated with the remote database.
  • health care providers, personal trainers, or other professionals may have access to the determined health parameter information and the plot of the determined health parameter as a function of time in order to inform clinical decisions and/or training programs.
  • an application e.g., a software application or an app
  • the EIM measurement device may capture a variety of other information including movement data, heart rate, and other readily obtainable data sets with a smartphone (e.g., auxiliary device 40) or the EIM measurement device itself.
  • the EIM measurement device may include circuits and features (e.g., impedance measuring fidelity, circuitry for measuring multiple frequencies, additional configurations, enhanced memory, extended ranges, etc.) adapted to measure abnormal EIM data. Additionally, the device may be configured to be handled by a weak individual (i.e., portable device having reduced weight, size, etc.).
  • the device may have (or be associated with) a display or a screen that is configured to display information to the patient (e.g., to inform the patient that a data upload was successfully completed, etc.).
  • a display or a screen that is configured to display information to the patient (e.g., to inform the patient that a data upload was successfully completed, etc.).
  • the screen of the auxiliary device 40 associated with the garment 30 may be used to convey information to the patient (e.g., to inform the patient that a data upload was successfully completed, etc.).
  • the screen may be adapted to display information in a simple and easily understandable manner. For example, in some embodiments, only a colored (e.g., green) symbol (e.g., check mark) may be shown to indicate that good data was obtained and/or uploaded.
  • a colored (e.g., green) symbol e.g., check mark
  • the EIM measurement device may be programmed to automatically acquire EIM signals from the patient at the desired frequency (e.g., on a preprogrammed schedule).
  • the garment 30 of FIG. 1A may be programmed to measure EIM signals every hour, etc.
  • the remote database (or device 50 of FIG. 1A) may send an instruction signal (e.g., on a periodic basis) to the garment 30 to take EIM measurements.
  • the application associated with the EIM measurement device (such as, an EIM measurement device of the ⁇ 98 patent or the ' 808 patent) may include an alarm to remind the patient or the caregiver to obtain their daily measurements.
  • the application may share an application program interface (API) with devices or sensors that collect other physiological data of the patient (movement data, heart rate, blood pressure, etc.,). This physiological data may be collected, uploaded, and analyzed along with the EIM data collected by the EIM measurement device.
  • API application program interface
  • EIM measurement device and/or the application may be configured to collect, store, and/or transmit input and/or oral communications from the patient and/or family. For example, in some embodiments, by pressing a button associated with the EIM measurement device (e.g., on the garment 30 of FIG. 1A), the patient may report what the patient is experiencing at a certain time (nausea, dizziness, etc.). This communication from the patient may also be uploaded along with the collected EIM data to the remote database. The data communicated by the patient may help in better analyzing and/or understanding the collected EIM data. In some embodiments, input related to surveys and/or questionnaires (e.g. ALS -Functional rating scale revised, etc.) may also be included in the data communicated by the patient. In some embodiments, the application may also provide dietary and exercise commentary to assist the patient in monitoring EIM data and/or the health more effectively.
  • a button associated with the EIM measurement device e.g., on the garment 30 of FIG. 1A
  • the frequent EIM data of method 200 may be used to reduce the number of subjects needed to be recruited into a clinical trial in neuromuscular disease, greatly reduce the duration of the trial, and/or greatly increase the sensitivity to a treatment effect (or any combination of these three effects).
  • outside of clinical trials the ability to follow individual patients during a course of treatment, to help ensure that the therapy is working
  • drug dosing either in a clinical trial or in individual patient care.
  • the patient's status could be tracked from one dose to a higher dose. If there is no specific change in the monitored health parameters at the higher dose, and
  • a similar approach can be used in studies of body composition and reduction in fat content or monitoring of body -region specific deposition of fat.
  • the disclosed frequent- measurement approach may have similar effects as described above, except that it may also impact other conditions and diseases beyond the realm of neuromuscular disease, including recovery and treatment for muscle injury, therapies focused on reducing body fat content and increasing muscle (such as for the prevention or treatment of type 2 diabetes), and for the evaluation of potential medication side effects impacting body composition, such as the use of corticosteroids.
  • the EIM measurement device and the disclosed frequent measurement technique may also be used to assist in the initial diagnosis of a neuromuscular condition. For example, patients with progressive disease may find alterations in their condition by performing daily measurements, even when less frequent measurements would not have revealed the alterations. Accordingly, frequent measurements may allow a practitioner to more quickly determine whether a disease requires treatment or not. Such frequent measurements may more clearly help in establishing efficacy effects, and therefore, may assist in the removal of bad data points.
  • An exemplary application of the disclosed frequent measurement approach may include a placebo-controlled, double-blind clinical trial in neuromuscular or other disease (e.g. diet therapy to reduce obesity).
  • some patients may receive the actual drug and others may receive a placebo.
  • Each patient may be provided an EIM measurement device to take home. They may be instructed to take daily measurements (i.e., frequently collect EIM data) on a set of muscles and regularly sync the device to the internet (either through phone or directly depending on the type of connection) to upload the collected data to a remote database. The patients may continue to take the drug/placebo for the length of the study.
  • an individual patient may be provided the EIM measurement device and placed on an FDA-approved therapy and the patient asked to perform
  • a physical therapist may provide the EIM measurement system to a patient while the patient is undergoing physical therapy.
  • the patient may be instructed to collect EIM data of the muscles being treated daily.
  • the collected data may be stored in the device or may be periodically uploaded to a database at the physical therapist's office. Based on a review of daily EIM data, the physical therapist thus might alter the treatment.
  • a specialist treating a patient with botulinum toxin for a variety of conditions may perform EIM measurements on a regular basis (daily, weekly, etc.).
  • the frequently collected data (or a health parameter computed using the EIM data) may indicate when it is time to again treat the patient with botulinum toxin. This would reduce delays in therapy and help ensure a patient's treatments are being accurately timed.
  • the disclosed frequent measurement technique may be used to assist with initial diagnosis of a patient.
  • a patient may complain of weakness that is progressive or other neuromuscular symptoms that are difficult to quantify.
  • the patient may be provided with an EIM measurement device and instructed to perform daily measurements over a period of several weeks or months.
  • the collected data may be stored in the EIM measurement device.
  • the patient may then return for follow up visit and the data analyzed.
  • the collected data may then be used to determine whether there is evidence of disease progression or not during that time period, or whether there are fluctuations in muscle status. This information may then be used for diagnostic purposes.
  • the EIM measurement device may be supplied to a patient to ensure that they are actively participating in a therapy or drug routine.
  • the device may also provide feedback data (potentially in real time) to help provide continuing encouragement to the patient.
  • an automatic feedback loop may be created whereby the patients self-adjust medication dosing based on continuous feedback from the EIM measurement device over a period of weeks or months.
  • the entire operation can become automated such that the device (or a remote database that analyzes the collected data) informs the patient of the appropriate dose based on the results of the frequent measurement data without the input (or with minimal input) of a physician or other medical professional.
  • a device implanted in the patient may release an appropriate dose of the drug based on input from the remote database.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Radiology & Medical Imaging (AREA)
  • Medical Informatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Primary Health Care (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Surgery (AREA)
  • Pathology (AREA)
  • Molecular Biology (AREA)
  • Physiology (AREA)
  • Business, Economics & Management (AREA)
  • General Business, Economics & Management (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rehabilitation Therapy (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)

Abstract

La présente invention concerne un dispositif de traitement portable destiné à un patient qui peut comprendre au moins une électrode couplée à un vêtement conçu pour être porté par le patient, ladite électrode étant conçue pour être placée en contact avec les tissus du patient et mesurer l'impédance électrique du patient ; et au moins un actionneur couplé de manière fonctionnelle au vêtement, ledit actionneur étant conçu pour administrer un traitement au patient en réponse à l'impédance électrique mesurée.
PCT/US2016/029812 2015-05-01 2016-04-28 Surveillance et conditionnement de tissus basés sur une myographie d'impédance électrique Ceased WO2016178907A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562155645P 2015-05-01 2015-05-01
US62/155,645 2015-05-01

Publications (1)

Publication Number Publication Date
WO2016178907A1 true WO2016178907A1 (fr) 2016-11-10

Family

ID=57218535

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2016/029812 Ceased WO2016178907A1 (fr) 2015-05-01 2016-04-28 Surveillance et conditionnement de tissus basés sur une myographie d'impédance électrique

Country Status (1)

Country Link
WO (1) WO2016178907A1 (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2599225A (en) * 2020-08-28 2022-03-30 Knitregen Ltd Muscle stimulation
EP4162974A1 (fr) * 2021-10-07 2023-04-12 Famidoc Technology Co., Ltd Instrument de physiothérapie doté d'une fonction de réglage de chauffage intelligent basé sur la rétroaction bioélectrique
US20250072758A1 (en) * 2023-08-30 2025-03-06 GS-HealthMatrix, LLC Systems, methods, and devices of wearable electro-acoustic monitoring

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070293918A1 (en) * 2006-06-15 2007-12-20 Thompson Thomas C Non-invasive neuro stimulation system
US20100105993A1 (en) * 2007-05-23 2010-04-29 Ic Therapeutics, Inc. Methods and apparatus for noninvasive ischemic conditioning
US8644925B2 (en) * 2011-09-01 2014-02-04 Zoll Medical Corporation Wearable monitoring and treatment device
US20140249613A1 (en) * 2013-03-04 2014-09-04 Zoll Medical Corporation Flexible therapy electrode
US20140257429A1 (en) * 2011-11-14 2014-09-11 Louise Mohn Stimulation Apparatus
WO2015056262A1 (fr) * 2013-10-18 2015-04-23 Healthwatch Ltd. Système autonome de surveillance de l'état de santé pouvant être porté, conçu pour faire l'interface avec un dispositif de traitement

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070293918A1 (en) * 2006-06-15 2007-12-20 Thompson Thomas C Non-invasive neuro stimulation system
US20100105993A1 (en) * 2007-05-23 2010-04-29 Ic Therapeutics, Inc. Methods and apparatus for noninvasive ischemic conditioning
US8644925B2 (en) * 2011-09-01 2014-02-04 Zoll Medical Corporation Wearable monitoring and treatment device
US20140257429A1 (en) * 2011-11-14 2014-09-11 Louise Mohn Stimulation Apparatus
US20140249613A1 (en) * 2013-03-04 2014-09-04 Zoll Medical Corporation Flexible therapy electrode
WO2015056262A1 (fr) * 2013-10-18 2015-04-23 Healthwatch Ltd. Système autonome de surveillance de l'état de santé pouvant être porté, conçu pour faire l'interface avec un dispositif de traitement

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2599225A (en) * 2020-08-28 2022-03-30 Knitregen Ltd Muscle stimulation
GB2599225B (en) * 2020-08-28 2023-01-04 Knitregen Ltd Muscle stimulation
EP4162974A1 (fr) * 2021-10-07 2023-04-12 Famidoc Technology Co., Ltd Instrument de physiothérapie doté d'une fonction de réglage de chauffage intelligent basé sur la rétroaction bioélectrique
US20250072758A1 (en) * 2023-08-30 2025-03-06 GS-HealthMatrix, LLC Systems, methods, and devices of wearable electro-acoustic monitoring

Similar Documents

Publication Publication Date Title
KR101649000B1 (ko) 혈관 건강 평가 방법 및 장치
Niazi et al. Changes in H-reflex and V-waves following spinal manipulation
JP6593656B2 (ja) 血液量モニタ
Paungmali et al. Hypoalgesic and sympathoexcitatory effects of mobilization with movement for lateral epicondylalgia
CN110650680B (zh) 用于监测血液和呼吸流量的设备
Fahs et al. Vascular adaptations to low-load resistance training with and without blood flow restriction
US10624579B2 (en) Biofeedback system with body mapping clothing for patients with adolescent idiopathic scoliosis
Melo et al. Effects of kinesio taping on neuromuscular performance and pain of individuals affected by patellofemoral pain: A randomized controlled trial
Jang et al. Validity and reliability of the newly developed surface electromyography device for measuring muscle activity during voluntary isometric contraction
WO2020078486A1 (fr) Dispositif de mesure de la force musculaire, procédé de détermination de la fonction musculaire, procédé de test de la performance musculaire d'athlètes, procédé de test de préparations pour le traitement et la prévention de la sarcopénie et son utilisation
AU2017239173A1 (en) An apparatus and method to locate, measure, monitor, and treat inflammation of the skin's soft tissue and fascia layers
Corley et al. Hemodynamic effects of habituation to a week-long program of neuromuscular electrical stimulation
US11517753B2 (en) Interferential treatment with modified beat frequency
MacLennan et al. The time course of neuromuscular impairment during short‐term disuse in young women
Zhu et al. Do cerebral potentials to magnetic stimulation of paraspinal muscles reflect changes in palpable muscle spasm, low back pain, and activity scores?
Guidi et al. Validation of smart textile electrodes for electrocardiogram monitoring in free-moving horses
Santiago-Pescador et al. Acute effects of electrostimulation and blood flow restriction on muscle thickness and fatigue in the lower body
Hanna et al. Bilateral NIRS measurements of muscle mitochondrial capacity: Feasibility and repeatability
WO2016178907A1 (fr) Surveillance et conditionnement de tissus basés sur une myographie d'impédance électrique
US20250275705A1 (en) Diagnostic system
Shimoura et al. Immediate effect of neuromuscular electrical stimulation on the abductor hallucis muscle: A randomized controlled trial
Harmon et al. Combined action observation and mental imagery versus neuromuscular electrical stimulation as novel therapeutics during short‐term knee immobilization
Ozsahin et al. Development of smart jacket for disc
Nikolic-Popovic et al. Measuring heart rate, breathing rate and skin conductance during exercise
Harmon The Effects of Neural and Mechanical Interventions on Muscle Size Versus Function During Short Term Immobilization of the Lower Limb

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 16789790

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205 DATED 19.03.2018)

122 Ep: pct application non-entry in european phase

Ref document number: 16789790

Country of ref document: EP

Kind code of ref document: A1